Tff Pharmaceuticals Inc (TFFP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,478 | 16,612 | 33,795 | 35,301 | 28,095 |
| Receivables | 434 | 187 | 2,595 | N/A | N/A |
| TOTAL | $7,590 | $19,025 | $38,838 | $37,559 | $29,187 |
| Non-Current Assets | |||||
| PPE Net | 2,000 | 3,078 | 1,860 | 1,103 | N/A |
| Other Non-Current Assets | 2,437 | 2,017 | 0 | 0 | 0 |
| TOTAL | $4,437 | $5,095 | $1,860 | $1,103 | $N/A |
| Total Assets | $12,027 | $24,120 | $40,698 | $38,662 | $29,187 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 958 | 920 | 1,494 | 1,298 | 411 |
| Accrued Expenses | 1,286 | 4 | 417 | N/A | N/A |
| TOTAL | $2,429 | $1,131 | $1,961 | $1,322 | $411 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 101 | 126 | 50 | 24 | N/A |
| Other Non-Current Liabilities | 32 | 110 | 0 | 0 | 1,132 |
| TOTAL | $32 | $110 | $N/A | $N/A | $1,132 |
| Total Liabilities | $2,460 | $1,241 | $1,961 | $1,322 | $1,543 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,519 | 1,448 | 1,015 | 926 | 747 |
| Common Shares | 2 | 1 | 25 | 23 | 19 |
| Retained earnings | -118,332 | -97,088 | -65,318 | -34,280 | -15,712 |
| Other shareholders' equity | -148 | -139 | -49 | -52 | 0 |
| TOTAL | $9,567 | $22,880 | $38,737 | $37,340 | $27,645 |
| Total Liabilities And Equity | $12,027 | $24,120 | $40,698 | $38,662 | $29,188 |